Evidence map›Paper›PMID 40928632›Full record

ReviewProbiotics and antimicrobial proteins2026

Genesis, Health Benefits, and Future Perspectives of Probiotics: Exploring Endogenous and Exogenous Classes, Innovations, and Research Gaps.

Alice Njolke Mafe, Obiekezie Obumneme Smart, Great Iruoghene Edo, Patrick Othuke Akpoghelie, Tayser Sumer Gaaz, Emad Yousif, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Shams A Ismael, Arthur Efeoghene Athan Essaghah and 3 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Association between probiotic prescriptions and the incidence of primary open-angle glaucoma in patients with documented dry eye.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alice Njolke MafeDepartment of Biological Sciences, Faculty of Science, Taraba State University Jalingo, Jalingo, Nigeria.
Obiekezie Obumneme SmartDepartment of Microbiology, Faculty of Natural and Applied Sciences, Nasarawa State University Keffi, Keffi, Nigeria.
Great Iruoghene EdoDepartment of Chemistry, Faculty of Science, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria. greatiruo@gmail.com.
Patrick Othuke AkpoghelieDepartment of Food Science and Technology, Faculty of Science, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria.
Tayser Sumer GaazDepartment of Prosthetics and Orthotics Engineering, College of Engineering and Technologies, Al-Mustaqbal University, Hillah, Babylon, Iraq.
Emad YousifDepartment of Chemistry, College of Sciences, Al-Nahrain University, Baghdad, Iraq.
Endurance Fegor IsojeDepartment of Science Biochemistry, Faculty of Science, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria.
Ufuoma Augustina IgbukuDepartment of Chemistry, Faculty of Science, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria.
Shams A IsmaelDepartment of Medical Physics, College of Science, Al-Nahrain University, Baghdad, Iraq.
Arthur Efeoghene Athan EssaghahDepartment of Urban and Regional Planning, Faculty of Environmental Sciences, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria.
Dina S AhmedDepartment of Chemical Industries, Institute of Technology-Baghdad, Middle Technical University, Baghdad, Iraq.
Dilber Uzun OzsahinDepartment of Medical Diagnostic Imaging, College of Health Sciences, University of Sharjah, P.O. Box 27272, Sharjah, United Arab Emirates.
Huzaifa UmarOperational Research Centre in Healthcare, Near East University, Nicosia, Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics are live beneficial microorganisms that confer health benefits to the host when administered in adequate amounts, have gained considerable scientific and commercial interest for their ability to support gut health, strengthen immunity, and reduce disease risk. This review traces the genesis of probiotic science from its origins in traditional fermented foods to contemporary clinical applications, offering a conceptual understanding of its evolution. A clear distinction is drawn between endogenous probiotics, naturally resident in the human microbiome, and exogenous probiotics, introduced via dietary supplements and functional foods. The broad spectrum of documented health benefits is examined, encompassing digestive, immune, metabolic, neurological, and dermatological outcomes. Recent innovations are highlighted, including bioengineered probiotic strains with targeted therapeutic functions, the integration of probiotics with prebiotics as synbiotics, and advanced delivery systems such as microencapsulation and nanotechnology. Special attention is given to regulatory frameworks, with global comparisons and a focused case study on Argentina, alongside a structured roadmap for translating research into market-ready products. The review also addresses inclusivity in probiotic use, emphasizing safety considerations across diverse populations, and underscores the strain-specific nature of probiotic effects. Current challenges such as commercialization gaps, regulatory inconsistencies, and underexplored applications in non-digestive health domains are critically discussed. The conclusion calls for interdisciplinary collaboration among microbiologists, nutritionists, clinicians, and technologists to accelerate innovation, ensure equitable access, and maximize the potential of probiotics in promoting health and preventing disease.

Indexed as

ProbioticsAnimalsDietary SupplementsEvidence GapsGastrointestinal MicrobiomeHumansPrebioticsPrebioticsEndogenousExogenousHealth benefitsProbioticsResearch gaps

Identifiers

PMID40928632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.